Global Urinary Tract Infection (UTI) Market 2022-2028

Garnering a CAGR of 3.5% from 2022 to 2028, the global urinary tract infection market is projected to reach worth of USD 10,785 million by 2028-end.

Urinary tract infections (UTIs) are common infections that happen when bacteria, often from the skin or rectum, enter the urethra, and infect the urinary tract. They usually occur in the bladder or urethra, but more serious infections involve the kidney. A bladder infection may cause pelvic pain, increased urge to urinate, pain with urination, and blood in the urine. A kidney infection may cause back pain, nausea, vomiting, and fever. Garnering a CAGR of 3.5% from 2022 to 2028, the global urinary tract infection market is projected to reach worth of USD 10,785 million by 2028-end, according to a new report The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global urinary tract infection market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the urinary tract infection industry.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug class, application, pathogen, end user, and region. The global market for urinary tract infection can be segmented by drug class: aminoglycosides, azoles, beta-lactam & cephalosporins, penicillin, quinolones, others. The quinolones segment held the largest share of the global urinary tract infection market in 2021 and is anticipated to hold its share during the forecast period. Urinary tract infection market is further segmented by application: cystitis, pyelonephritis, urethritis, others. Globally, the urethritis segment made up the largest share of the urinary tract infection market. Based on pathogen, the urinary tract infection market is segmented into: Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus saprophyticus, others. On the basis of end user, the urinary tract infection market also can be divided into: clinics, hospitals, self administered, others. Urinary tract infection market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW). By drug class: - aminoglycosides - azoles - beta-lactam & cephalosporins - penicillin - quinolones - others By application: - cystitis - pyelonephritis - urethritis - others

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Arun Kalwani

Arun Kalwani

Research Analyst

By pathogen: - Enterococcus faecalis - Escherichia coli - Klebsiella pneumoniae - Proteus mirabilis - Staphylococcus saprophyticus - others By end user: - clinics - hospitals - self administered - others By region: - North America - Asia Pacific - Europe - Rest of the World (ROW)

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Arun Kalwani

The report also provides a detailed analysis of several leading urinary tract infection market vendors that include Allergan plc, Bayer AG, Cipla Limited, Eli Lily Company, GSK plc, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global urinary tract infection market. - To classify and forecast the global urinary tract infection market based on drug class, application, pathogen, end user, region. - To identify drivers and challenges for the global urinary tract infection market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global urinary tract infection market. - To identify and analyze the profile of leading players operating in the global urinary tract infection market. Why Choose This Report - Gain a reliable outlook of the global urinary tract infection market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • · Impact of COVID-19 pandemic
  • PART 5. MARKET BREAKDOWN BY DRUG CLASS
  • · Aminoglycosides
  • · Azoles
  • · Beta-lactam & cephalosporins
  • · Penicillin
  • · Quinolones
  • · Others
  • PART 6. MARKET BREAKDOWN BY APPLICATION
  • · Cystitis
  • · Pyelonephritis
  • · Urethritis
  • · Others
  • PART 7. MARKET BREAKDOWN BY PATHOGEN
  • · Enterococcus faecalis
  • · Escherichia coli
  • · Klebsiella pneumoniae
  • · Proteus mirabilis
  • · Staphylococcus saprophyticus
  • · Others
  • PART 8. MARKET BREAKDOWN BY END USER
  • · Clinics
  • · Hospitals
  • · Self administered
  • · Others
  • PART 9. MARKET BREAKDOWN BY REGION
  • · North America
  • · Asia Pacific
  • · Europe
  • · Rest of the World (ROW)
  • PART 10. KEY COMPANIES
  • · Allergan plc
  • · Bayer AG
  • · Cipla Limited
  • · Eli Lily Company
  • · GSK plc
  • · Merck & Co. Inc.
  • · Novartis AG
  • · Novo Nordisk A/S
  • · Pfizer Inc.
  • · Teva Pharmaceutical Industries Ltd.
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Global Urinary Tract Infection (UTI) Market 2022-2028

We are friendly and approachable, give us a call.